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Critically important to the maintenance of the glutathione (GSH) redox cycle are the activities of many selenocysteine-containing GSH metabolizing enzymes whose translation is controlled by the epitranscriptomic
writer alkylation repair homolog 8 (ALKBH8). ALKBH8 is a tRNA methyltransferase that methylates the wobble
uridine of specific tRNAs to regulate the synthesis of selenoproteins. Here we demonstrate that a deficiency in
the writer ALKBH8 (Alkbh8def), alters selenoprotein levels and engages senescence, regulates stress response
genes and promotes mitochondrial reprogramming. Alkbh8def mouse embryonic fibroblasts (MEFs) increase
many hallmarks of senescence, including senescence associated β-galactosidase, heterocromatic foci, the cyclin
dependent kinase inhibitor p16Ink4a, markers of mitochondrial dynamics as well as the senescence associated
secretory phenotype (SASP). Alkbh8def cells also acquire a stress resistance phenotype that is accompanied by an
increase in a number redox-modifying transcripts. In addition, Alkbh8def MEFs undergo a metabolic shift that is
highlighted by a striking increase in the level of uncoupling protein 2 (UCP2) which enhances oxygen consumption and promotes a reliance on glycolytic metabolism. Finally, we have shown that the Alkbh8 deficiency
can be exploited and corresponding MEFs are killed by glycolytic inhibition. Our work demonstrates that defects
in an epitransciptomic writer promote senescence and mitochondrial reprogramming and unveils a novel
adaptive mechanism for coping with defects in selenocysteine utilization.

1. Introduction
The epitranscriptome can serve to regulate translation through posttranscriptional modification of RNAs and its dysregulation is associated
with disease and toxicant susceptibility [1–6]. Alkylation repair
homolog 8 (ALKBH8) is an epitranscriptomic writer with tRNA methyltransferase activity and it can methylate the wobble uridine on
tRNASec 7,8. ALKBH8 is required to complete the formation of 5-methoxycarbonylmethyluridine (mcm [5]U) and 5-methoxycarbonylmethyl2′-O-methyluridine (mcm [5]Um), and these RNA modifications promote UGA-stop codon recoding which is needed for the incorporation of
the rare 21st amino acid selenocysteine (Sec) [7–10]. We have shown
that ALKBH8 protein levels, stop-codon recoding and ALKBH8-dependent uridine wobble base modifications are increased in response to
reactive oxygen species (ROS) stress to improve the translation of selenocysteine containing glutathione peroxidase (GPX) and thioredoxin
reductase (TRXR) enzymes [11], supporting the idea that the epitranscriptomic writer ALKBH8 is a ROS sensor and effector.

∗

Senescence is a form of replicative arrest which is triggered by a
variety of stressors including but not limited to DNA damage, telomere
erosion, and oxidative stress [12]. While senescence is beneficial as an
innate tumor-suppressive mechanism responsible for inducing permanent replicative arrest in cells at risk of malignant transformation, it has
been established that the accumulation of senescent cells with increasing age is deleterious in tissue microenvironments in vivo [13].
Upon senescent transformation, cells adopt a modulated secretome
termed the senescence-associated secretory phenotype (SASP), increasing secretion of inflammatory cytokines, matrix metalloproteinases (MMPs), chemokines, and growth factors into the surrounding
tissue microenvironment [14]. Through its ability to evoke responses
from cells in a paracrine fashion, SASP has been linked to numerous
age-associated disease pathologies including tumor invasion, cardiovascular dysfunction, neuroinflammation, osteoarthritis and renal disease [15–18].
While there is wealth of information linking senescence to many
degenerative disease processes [17–22] the role of selenium in the
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regulation of the senescence program has only recently been unveiled.
Se supplementation can extend the replicative lifespan of cells in culture [23] and Se deprivation or supplementation can accelerate or delay
the production of senescence associated markers, respectively [23–25].
While serum selenium levels are predictors of longevity and healthy
aging [26–28] selenium deprivation has also been shown to promote
longevity [29]. Selenium is functionally utilized by small repertoire of
enzymes as Sec, which is incorporated translationally through the use of
UGA stop codon recoding and under epitranscriptomic control. However, little is known with respect to the specific contribution of epitranscriptomic writers that control Sec utilization in regulating senescence. In this study, we show that deficiency in ALKBH8 engages
senescence, mitochondrial reprogramming and confers a survival advantage to cells with a limited capacity to incorporate selenocysteine.
Increases in selenoncysteine containing proteins are often associated
with chemoresistance and these findings indicate that therapeutic
strategies to impede selenoprotein activity may further accentuate drug
resistance and confer and advantageous survival advantage.

2.4. Western blot
Cell were washed twice with cold phosphate-buffered saline (PBS)
and lysed with radioimmunoprecipitation (RIPA) lysis buffer. The lysates were centrifuged for 15 min at full speed at 4 °C. For sample
preparation, 15 μg of whole cell lysates were used and 6X SDS sample
buffer with 10% of 0.5 M DTT added to each sample prior to boiling for
15 min. The samples were then separated on an 8% SDA-polyarylamide
gel (Thermo Fisher Scientific, Waltham, MA) and transferred onto nitrocellulose membrane (Thermo Fisher Scientific, Waltham, MA). The
membrane was blocked with 5% dry milk in 0.1% Tris-buffered salineTween 20 for 1 h and incubated overnight at 4 °C with primary antibodies, UCP2 (1:400) (Santa Cruz Biotechnology, Dallas, TX), Mitofusin
1 (1:500) (Cell Signaling Technology, Danvers, MA), Mitofusin 2
(1:500) (Cell Signaling Technology, Danvers, MA), Drp1 (1:500) (Cell
Signaling Technology, Danvers, MA), GAPDH (1:10000) (Santa Cruz
Biotechnology, Dallas, TX), Alkbh8 (1:1000) (ABclonal, Woburn, MA),
GPX1 (1:1000) (R&D Systems, Minneapolis, MN), and TRXR2 (1:1000)
(ABCAM, Cambridge, MA) followed by incubation with respective
secondary antibodies, either anti-mouse (1:10000) (Cell Signaling
Technology, Danvers, MA), anti-goat(1:10000) (ABCAM, Cambridge,
MA) or anti-rabbit (1:10000) (Cell Signaling Technology, Danvers, MA)
for 1 h. The membranes were developed by Supersignal West Femto
Maximum sensitivity substrate kit (Thermo Fisher Scientific, Waltham,
MA) and imaged with ChemiDocTM imaging system (BIO-RAD,
Hercules, CA).

2. Materials and methods
2.1. Cell culture
Both wild type (WT) Mouse Embryonic Fibroblasts (MEFs) and
Alkbh8 deficient (Alkbh8def or Def) MEFs were cultured in Dulbecco's
Modified Eagle's Medium (DMEM) (Corning Inc., Corning, NY) supplemented with 10% fetal bovine serum (Corning Inc., Corning, NY),
10% non-essential amino acids (Corning Inc., Corning, NY), 100 Units/
mL penicillin and 100 μg/ml streptomycin, at 21% oxygen tension at
37 °C and 5% CO2. These cells were lifted in 0.25% trypsin/EDTA
(Corning Inc., Corning, NY) and serially passaged at a dilution of 1:6.
Primary human fetal lung fibroblasts (IMR90) were cultured in
Minimum Essential Medium (MEM) (Corning Inc., Corning, NY) supplemented with 10% fetal bovine serum and incubated at 21% oxygen
tension at 37 °C with 5% CO2. These cells were lifted in 0.25% trypsin/
EDTA and serially passaged at a dilution of 1:4.
To analyze cell viability in different oxygen concentration, cells
were cultured in 21% and 3% O2 for 5 days and counted every 24 h.

2.5. SA-β-gal staining
Senescence Associated β-Galactatosidase (SA-β-Gal) staining was
performed using senescence-galactosidase staining kit (Cell Signaling
Technology, Danvers, MA) as per manufacturer's protocol. Briefly, cells
were seeded in 6-well tissue culture plates overnight and washed once
with PBS. 1 ml of 1x fixative solution was added and incubated for
15 min at room temperature. The plates were washed twice with PBS
and stained with 1 ml of β -Gal staining solution for overnight at 37 °C
in a dry non-CO2 incubator. Images were taken in nine random fields
using light microscopy and β-gal-positive cells are presented as intensity normalized to WT MEFs using ImageJ software.

2.2. Cytotoxicity and colony formation

2.6. Heterochromatin foci staining

10,000 cells per well were seeded in 96 well plates (Celltreat,
Pepperell, MA) and were treated for 24 h with 2 deoxy-glucose (2DG)
(Cayman, Ann Arbor, MI) at indicated concentrations to measure cytotoxicity. Cells were then stained with crystal violet, followed by solubilizing with 10% acetic acid and absorbance was measured with Flex
Station 3 plate reader (Molecular Devices, San Jose, CA) at a wavelength of 570 nm. 500 cells per well were seeded in 24 well plates with
0.31 mM 2DG. Cells were grown for 5 days and colonies formed were
stained using crystal violet. Colonies of 15 or more cells were counted
for quantification and surviving fraction was calculated as (number of
colonies formed/500 cells plated).

Cells were seeded on coverslips in 6-well tissue culture plates
overnight, followed by fixation of the cells with cold 4% formaldehyde
solution for 15 min at room temperature. The plates were washed once
with cold PBS and the coverslips were mounted on glass slides with
ProlongTM Gold Antifade Mount containing DAPI (Thermo Fisher
Scientific, Waltham, MA). The slides were left overnight to dry in the
dark and sealed with clear nail polish. Images were taken in three
random fields using florescent microscope and heterochromatin foci
positive nuclei are presented as percentage of total number of counted
nuclei.

2.3. Quantitative RT-PCR

Oxygen Consumption rate (OCR), and extracellular acidification
rate (ECAR) were measured at 37 °C as per manufacturer's protocol for
the seahorse XF24 extracellular flux analyzer (Agilent Technologies,
Santa Clara, CA). Briefly, cells were seeded in 24-well tissue culture
plate overnight, allowing the cells to adhere. Due to differences in
proliferative capacity between cell types, cells were seeded at differing
densities so that cell numbers were equivalent at time of metabolic flux
analysis. On the day of analysis, Cells were changed to conditional
seahorse assay media at pH 7.4 supplemented with 25 mM glucose and
1 μM sodium pyruvate. Cells were incubated in non-CO2 incubator at
37 °C for 1 h and respiration was measured before and after injection of

2.7. Mitochondrial oxygen consumption rate

In brief, total mRNA was extracted from respective cell lines using
TRIzol reagents (Life Technologies, Carlsbad, CA) as described by
manufacturer. cDNA was synthesized from 500 ng total mRNA using
Maxima H Minus First strand kits (Thermo Fisher Scientific, Waltham,
MA). Real-time quantitative RT-PCR was performed in triplicates on a
7500 PCR system (Applied Biosystems, Förster city, MA) and the sequences were described in Supplementary Table 1. Additional oxidative
stress and antioxidant defense regulated genes were also analyzed using
RT [2] profiler PCR array (Qiagen, Hilden, Germany).
2
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three compounds: oligomycin (1 μM), carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP) (3 μM), and rotenone (1 μM).
Immediately after the run, cells were lysed in RIPA buffer and the
protein concentration was measured using BCA assay. The results were
normalized with the protein OD value of corresponding wells and OCR,
ECAR and cell energy phenotype were automatically calculated by
Wave software (Agilent Technologies, Santa Clara, CA).
2.8. Mitotracker green staining
Cells were seeded on cover-slips for 24 h to reach desired confluency. The cells were then stained with 200 nM MitoTracker Green
(Invitrogen, Carlsbad, CA) and incubated for 15 min at 37 °C. After incubation period, cells were washed once with PBS and fixed with 4%
formaldehyde solution for 15 min at room temperature. The plates were
then washed once with cold PBS and the coverslips mounted on glass
slides with ProlongTM Gold Antifade Mount. The slides are immediately
imaged using 60x oil immersion objective (Zeiss, Oberkochen,
Germany). The morphology and the length of the mitochondria are
measured using Fiji-ImageJ [30,31]. Briefly, MiNA macro tool was installed in Fiji from https://github.com/ScienceToolkit/MiNA as per
instructions. After opening the images with Fiji software, granular noise
is remover (process →Noise→Despeckle) and local contrast enhancement performed to improve the binary image quality, as well as better
visualization of small, dendritic mitochondria (Process→Enhance Local
Contrast (CLAHE). Plugins→Analyze→Tubeness was perform to see the
mitochondrial network. And the morphology of the mitochondria were
analyzed in following steps; Process→Binary→Make Binary, Process→
Binary→skeletonize, Analyze→Skeleton→Analyze Skeleton(2D/3D),
and Plugins→Stuart Lab→MiNA Scripts→MiNA Analyze Morphology.

Fig. 1. Alkbh8 deficiency impedes cell growth, induces p16Ink4a and is
observed in senescent human diploid fibroblast IMR-90 cells. A) Growth of
Alkbh8def and WT MEFs in 21% and 3% O2. B) RT-PCR transcript levels p16Ink4a
and p21 from wild type (WT) and Alkbh8 deficient (def) cells. All data was
normalized to β-actin controls. Data shown are the mean ± SEM, ***,
p ≤ 0.001 when compared to WT. C) RT-PCR transcript levels of Alkbh8 from
young and old (senescent) human diploid fibroblast IMR90 cells culture in low
and high oxygen. Data shown are the mean ± SEM, ***, p ≤ 0.001.

selenocysteine containing proteins. Supplementary Table 2 summarizes
our findings indicating that there is a robust increase in the levels of
number of key oxidant-metabolizing genes, including Superoxide dismutase 2 (Sod2), neutrophil cytosol factor1 (Ncf1), Uncoupling protein
2 and 3 (Ucp2 and Ucp3) and glutathione peroxidase 3 and 6 (Gpx3 and
Gpx6). Indicating that selenoprotein deficiency is accompanied by
adaptive increases in the transcripts of oxidant-metabolizing genes. We
next evaluated whether the increased oxidizing capacity of Alkbh8def
cells activate the senescent program. We first characterized the proliferative capacity of Alkbh8def cells as cellular senescence is accompanied by growth arrest. As shown in Fig. 1A, Alkbh8def MEFs display a
significant proliferative defect, compared to their WT controls, that is
reversed by growth in low oxygen (3% O2). The tumor suppressor
p16INK4a has been well established as a senescence marker and its expression was significantly upregulated in Alkbh8def MEFs (Fig. 1B) while
the cell cycle regulator p21 was not. We next set out to determine if
replicative senescence, which is observed in primary human diploid
cells, is accompanied by alterations in the levels of Alkbh8. Transcript
levels of Alkbh8 were decreased in senescent IMR-90 human diploid
fibroblasts, relative to pre-senescent cells, which was reversed by culturing cells in 3% O2 (Fig. 1C). These, observations suggest that Alkbh8
depletion is associated with proliferative defects linked to the senescence program.
Cellular senescence is also associated with the formation of heterochromatin foci (HCF), which are enriched in chromatin modifications. HCF can be monitored using high magnification fluorescence
microscopy in combination with DAPI staining as in Fig. 2A, demonstrating significant enrichment of HCF in Alkbh8def MEFs. Senescence
associated beta-galactosidase (SA-β-gal) is also a key indicator of senescence engagement and can be detected at pH 6 in single cells using
X-Gal staining [32]. Alkbh8def cells display significant increases in SA-βgal staining compared to WT (Fig. 2B). The senescence associated secretary phenotype is common to all forms of senescence and is causal to
age-related decline in organ function [33]. We have established that the
senescence associated secretory phenotype is under redox-control [14]
and it is likely that oxidative stress that accompanies the impairment in
selenoprotein exacerbates SASP. As shown in Fig. 3, the levels of many
of the most prominent SASP markers are dramatically upregulated

2.9. 2′,7′-dichlorodihydrofluorescein diacetate (H2DCFDA) staining
Cells were seeded in 96-well black/clear bottom plate with or
without 20 μM genipin treatment overnight. On the day of assay, the
cells were washed once with PBS, and treated with 300 μM H2O2 for
30 min at 37 °C. The cells were then washed once with PBS and stained
with 30 μM cell-permeant oxidation-sensitive dye H2DCFDA
(Invitrogen, Carlsbad, CA) for 30 min at 37 °C, followed by fluorescence
analysis (485 nm excitation, 535 nm emission) with Flex Station 3 plate
reader.
The
oxidation-insensitive
dye
5(6)-carboxyl-2′,7′-dichlorodihydrofluorescein diacetate (CDCF) (Invitrogen, Carlsbad, CA)
was used as control so that any fluorescence changes between groups
with H2DCFDA is directly attributed to changes in the dye oxidation.
Mean fluorescent values for H2DCFDA-treatment cells were normalized
to values of the control CDCF-treated cells.
2.10. Statistical methods
Data were analyzed using GraphPad Prism version 8 software. All
statistical analyses were performed with the GraphPad Prism 8.0 statistical software package. Statistical significance was assessed using the
two-tailed Student's t-test or one-way ANOVA with Tukey-Kramer posttest. P values of <0.05 were considered significant.
3. Results
3.1. Alkbh8 deficient cells engage cellular senescence
We have established that Alkbh8 deficiency limits selenoprotein
synthesis, elevating cellular ROS levels [11] (Supplementary Figure 1),
and that increases in steady state H2O2 production drive SASP [14]. We
first performed a focused array using Qiagen's Oxidative Stress and
Antioxidant Defense RT [2] Profiler PCR Array to evaluate potential
adaptive oxidant metabolizing genes that aid in the survival of cells
deficient in Alkbh8 and the absence of many functional key
3
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Fig. 2. Alkbh8 deficiency increases senescence associated heterochromatic foci and senescence associated β-galactosidase levels. A) WT and Alkbh8def MEFs
stained with DAPI (left panels) and imaged at differing fluorescence intensities (upper and lower panels) to accentuate stained nuclei. Quantification of HCF (n = 5),
(right panel). B) Senescence-Associated β-galactosidase staining of WT and Alkbh8def MEFs (left panels) and quantification (n = 3), (right panel). Data shown are the
mean ± SEM, **, p ≤ 0.01 and *, p ≤ 0.05 for A and B, respectively.

response to cell stress [36] and is controlled by key fusion (MFN1,
MFN2 and OPA1) and fission associated proteins (FIS1 and DRP1).
Analysis of a subset these fusion and fission proteins revealed no change
in the levels of the fusion proteins MFN1 and MFN2 but a striking decrease in the levels of the fission protein DRP1 (Fig. 4B) in Alkbh8def
cells. Decreases in the levels of fission to fusion related proteins may in
part explain the elongated mitochondrial structure in the Alkbh8 deficient MEFs. Overall, the above findings support the idea that mitochondria play an important role in adapting to epitranscriptomic
defects.
3.3. Alkbh8 deficiency engages mitochondrial reprogramming
The resulting increase in mitochondrial length that accompanies
Alkbh8 deficiency led us to investigate mitochondrial function. We
monitored mitochondrial oxygen consumption and glycolytic flux in
Alkbh8def MEFs using the XF24 Analyzer (Seahorse Biosciences). Due to
differences in proliferative capacity between cell types (Fig. 1A) and the
need for standard 24-h plate equilibration, cells were seeded at differing densities so that cell numbers were equivalent at time of metabolic flux analysis. Alkbh8def MEFs display significant increases in basal,
maximal and non-mitochondrial respiration and extracellular acidification compared to WT MEFs (Fig. 5A and B). The cell energy phenotype indicates that Alkbh8def MEFs display energetic adaptation utilizing both aerobic and glycolytic metabolism in response to
mitochondrial stress (Fig. 5C) which is also reversed by Alkbh8 rescue
(Supplementary Fig. 4).

Fig. 3. Alkbh8 deficiency engages the Senescence Associate Secretory
Phenotype. RT-PCR of indicated SASP transcripts in control and Alkbh8def
MEFs (n = 3). Data shown are the mean ± SEM, *, p ≤ 0.05, **, p ≤ 0.01, ***,
p ≤ 0.001 when compared to WT.

when selenocysteine utilization is impaired by Alkbh8 deficiency. Further, Alkbh8 rescue negated any increases in SASP and HCF observed in
the Alkbh8def cells (Supplementary Figure 2). Thus, Alkbh8 deficiency is
clearly responsible for the increase in senescent marks.
3.2. Alkbh8 deficiency engages mitochondrial reprogramming

3.4. UCP2 plays a role in mitochondrial adaptation observed in Alkbh8Def

Mitochondrial fusion has also been shown to play an important role
in adapting to stress and increased fusion events are correlated with
senescence [34,35]. To determine if a deficiency in the epitranscriptomic writer ALKBH8 alters mitochondrial morphology, we performed mitochondrial staining using mitotracker green in combination
with Fiji-ImageJ. Alkbh8def cells display a significant increase in mean
mitochondrial length and mean summed branch length when compared
to WT, while other mitochondrial network parameters remain the same.
(Fig. 4A, Supplementary Fig. 3). Fusion serves a protective function in

Uncoupling protein 2 (Ucp2) was one of the most highly expressed
genes in our focused array analyses and its expression has been reported
to increase upon irradiation induced senescence [37], thus we tested
whether its upregulation might explain the altered functional activity of
mitochondria in the Alkbh8def cells. UCP2, is found in the inner mitochondrial membrane and plays a key role in uncoupling ATP synthase
from electron transport chain as well as in limiting mitochondrial ROS
4
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Fig. 4. Alkbh8 deficiency is accompanied by increases in mitochondrial length which is associated with a decrease in fission related protein DRP1. A) WT
and Alkbh8def MEFs were stained with 200 nM Mitotracker green for 15 min and live-imaged using Zeiss Z1 inverted fluorescence microscope. The lengths of 100
randomly selected mitochondrial were measured using ImageJ (n = 10). The box plots show median (middle Horizontal lines), first to third quartile (box), and min
and max (outer horizontal lines) with *, p ≤ 0.05. B) Immunoblot analysis of fission and fusion proteins from WT and Alkbh8def cells and accompanying quantitative
analysis (n = 3). Data shown are the mean ± SEM, ***, p ≤ 0.001 for mitochondrial length and *, p ≤ 0.05 for DRP1. (For interpretation of the references to colour
in this figure legend, the reader is referred to the Web version of this article.)

extracellular acidification in Alkbh8def MEFs but in the presence and
absence of the UCP2 inhibitor genipin. As in Fig. 5, Alkbh8def MEFs
display significant increases in basal, maximal and non-mitochondrial
respiration and extracellular acidification compared to WT MEFs, both
of which are negated by treatment with UCP2 inhibitor, genipin
(Fig. 6B). In addition, the cell energy phenotype indicates that Alkbh8def
MEFs display energetic adaptation utilizing both aerobic and glycolytic
metabolism in response to mitochondrial stress and this adaptation is

production by decreasing electron leak [38]. We first confirmed its
expression at both the transcript and protein levels (Fig. 6A). Interestingly, limiting metabolic oxygen exposure with low oxygen (3% O2)
tempered the elevations in Ucp2 expression that accompany Alkbh8
deficiency. The effects of elevated UCP2 on mitochondrial function vary
and both inhibitory as well stimulatory activity have been observed
[39].
We next measured mitochondrial oxygen consumption and

Fig. 5. Alkbh8 deficiency is accompanied by an
increase oxygen consumption and extracellular
acidification. A) Extracellular Flux analysis of WT
and Alkbh8def MEFs using XF24 analyzer. The graphs
represent the kinetic profiles of oxygen consumption
rate (OCR), and extracellular acidification rate
(ECAR) in WT and Alkbh8def MEFs. B) The bar graph
represents the quantitative analysis of basal respiration, ATP production, non-mitochondrial respiration,
proton leak, maximal respiratory, and reserve respiratory capacity. Cell energy phenotype display
shift toward glycolysis in Alkbh8def MEFs. The data
represents mean ± SEM, n = 5, *, p ≤ 0.1, **,
p ≤ 0.01. C) Cell energy phenotype profile was obtained using XF report generator. All data are calculated and displayed as absolute OCR vs. absolute
ECAR. Baseline OCR and ECAR (presented as open
markers) are calculated from the last rate measurement before any injection and the stressed OCR and
ECAR (presented as filled markers) represent the
maximum rate measurement after FCCP injection.

5
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Fig. 6. Alkbh8def drives UCP2 upregulation and
augments metabolic flux. A) UCP2 expression in
Alkbh8def MEFs. All data was normalized to GAPDH
controls and presented as mean ± SEM. ***,
p ≤ 0.001 when compared to WT, ##, p = 0.003
when compared to 21% O2 Alkbh8def. Inset, representative UCP2 immunoblot (n = 3) and densitometry obtained using ImageJ. **, p ≤ 0.01 when
compared to WT. B) Cell Mito Stress analysis as in
Fig. 5 with n = 3 C) Cell energy phenotype as in
Fig. 5 with n = 3.

not observed when cells were treated with genipin (Fig. 6C). These
findings not only confirm that UCP2 is abundantly expressed in the
Alkbh8def cells but that its expression is of functional significance.
3.5. Alkbh8Def cells rely on glycolysis for survival and are resistant to
arsenic containing mitochondrial toxins
As the Alkbh8def cells display a glycolytic adaptation in their cell
energy phenotype, we evaluated their sensitivity to the glycolytic inhibitor 2-deoxyglucose (2DG). Alkbh8def are significantly more sensitive
to 2DG than their WT counterparts (Fig. 7A). In addition, while the
Alkbh8def MEFs display a proliferative defect to growth in ambient air,
they are unusually resistant to a number of arsenicals which have been
shown modulate mitochondrial ROS levels [40] (Supplementary Figure
5) and display self-sufficiency (high clonogenic activity) relative to WT
MEFs that is blocked in response to 2DG treatment (Fig. 7B) which is
reversed by Alkbh8 rescue (Supplementary Figure 6).
4. Discussion
Epitranscriptomic writer deficient cells adapt by engaging senescence, reprogramming stress response systems and altering
mitochondrial function.
Our previous work demonstrated cellular senescence increases H2O2
production and engages the senescence associated secretory phenotype
(SASP) [41–44]. Our objective here was to determine whether defects
in an epitranscriptomic writer linked to Sec utilization leads to a similar
redox-based activation of the senescent program. Here we report that
selenoprotein loss resulting from Alkbh8 deficiency limits H2O2 removal
and engages the senescence program. Selenoprotein loss resulting from
selenium restriction can also induce senescence which is reversed by
selenium supplementation [24,45]. The Alkbh8def mice may therefore
be a good model to mimic a dietary loss of selenium. As Alkbh8 deficiency increases DNA damage and enhances basal oxidant production
[11], we first demonstrated that Alkbh8def MEFs display a proliferative
defect, which is reversed when cells are cultured in a low oxygen
condition. The ability of low oxygen to delay senescence associated
proliferative defects was first reported by Ames and confirmed by
others [46,47] and similar to these reports the reversal of the growth

Fig. 7. Alkbh8def increases sensitivity to glycolytic inhibition. A)
Cytotoxicity assay using crystal violet stain was performed with 2DG treatment
at various dosages for 24 h. B) Clonogenicity of WT and Alkbh8def MEFs. The
statistical comparison between untreated versus treated cells was presented as
mean ± SEM, ****, p ≤ 0.0001 and ####, p ≤ 0.0001 compared to Alkbh8def
2DG treated. (For interpretation of the references to colour in this figure legend,
the reader is referred to the Web version of this article.)

impediment of the Alkbh8def MEFs is likely attributed to reduction in
metabolic H2O2.
While senescence engagement is only one mechanism by which cells
adapt to oxidant burden, they often compensate by increasing
6
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Fig. 8. Epitranscriptomic systems that regulate selenoprotein levels modulate senescence and mitochondrial function.

antioxidant enzyme levels or limiting mitochondrial electron leak [48].
The compensatory increase in many redox modifying genes is likely, in
part, responsible for the enhanced stress resistance of Alkbh8def cells.
Interestingly many of these oxidant metabolizing systems are commonly upregulated during carcinogenesis, oncogenic transformation
and metastatic disease [49].
Like senescent cells, Alkbh8def MEFs display increased mitochondrial
mass, ROS production, oxygen consumption and decrease ATP production [50]. A number of ALKBH family members have also been
linked to defects in mitochondrial function. ALKBH1 is involved in
biogenesis of 5-formyl-2′-O-methylcytidine (f5Cm) at position 34 and
loss Alkbh1 decreases mitochondrial translation and reduced respiratory complex activities [51]. ALKBH7 can trigger the collapse of
mitochondrial membrane potential, energy depletion, and loss of mitochondrial function, which leads to oxidation induced programmed
necrosis [52]. Thus, defects in the ALKBH family activity cause mitochondrial dysfunction with the potential to increase ROS production
promote DNA damage and senescence growth arrest [53].
Mitochondria also cope with stress by controlling fusion/fission
processes [54] and mitochondrial elongation is a common phenotype in
response to energy stress involved in tumor cell survival [55]. The
length of mitochondria and its dynamics are determined by the balance
between fusion (MFN1, MFN2 and OPA1), and fission proteins (FIS1
and DRP1) [56,57]. The ratio of fusion and fission proteins is critical in
disease-related processes such as apoptosis, mitophagy and cell survival
[58]. Mitochondrial fusion has also been shown to play an important
role in adapting to stress and increase in fusion events are correlated
with senescence [34]. Loss of UCP2 is associated with an increase in
fragmentation and decrease in the ratio of fusion/fission related proteins which is reversed by UCP2 overexpression [59], indicating that
UCP2 may assist in driving the fusion processes. Our findings indicate
that although no change was detected in MFN1 and MFN2 levels, Alkbh8def MEFs display a significant decrease in the fission protein, DRP1,
resulting in an increase of ratio of fusion and fission which likely promotes mitochondrial elongation. Whether this is a UCP2 mediated
process remains to be determined.

Increased UCP2 has been reported to limit mitochondrial oxidant
production and participate in many physiological processes including
glucose and fatty acid utilization [60] and linked to type 2 diabetes and
cancer [61–68]. Arsenic containing compounds are mitochondrial
toxins that disrupt ATP production and are often lethal to normal cells
[69,70]. Thus, increased UCP2 may promote survival of the Alkbh8def
MEFs in response to arsenic by limiting ROS production. Resistance to
arsenic containing compounds but high sensitivity to 2DG indicates that
glycolytic adaptation is also important to the survival of Alkbh8def
MEFs. While the proliferative capacity of Alkbh8def MEFs is also impaired they display a significant survival advantage when grown at low
seeding density compare to the WT MEFs. High clonogenic activity,
stress resistance and a reliance on glycolysis for survival are key features of tumorigenic cell lines [71] and it is possible that conditions
which limit ALKBH8 activity may potentiate tumorigenic activity.
4.1. Epitranscriptomic defects and adaptive phenotypes can be exploited to
kill senescent cells
It is clear from our findings that cells adapt dramatically to the loss
of ALKBH8 and defects in selenoprotein levels. In addition to mcm [5]U
and mcm [5]Um modifications by ALKBH8, tRNASec contains 2 modified bases at the T-arm, 1-methyladenosine (m1A) at position 58 and
pseudouridine (Ψ) at position 55, and one modified base at anti-codon
arm, N [6]-isopentenyl-adenosine (i6A) at position 37 [72]. m1A modification is required for Ψ synthesis, which is essential for maintaining
the tertiary structure of tRNASec [73]. I6A modification of tRNA[Ser]Sec
catalyzed by tRNA isopentenyltransferase 1 (TRIT1) is required for
decoding of UGA stop codon, as well as selenoproteins synthesis [74]
and knock down of TRIT1 reduces selenoprotein expression [75].
Whether selenoprotein defects can engage cellular senescence and the
relation between other epitranscriptomic modifications of tRNASec and
cellular senescence need to be further investigated.
Senescence has emerged as a key therapeutic target for many disease interventions as its abatement in distinct murine models limits age
related decline in cognitive, cardiac and renal function, muscle atrophy,
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cataracts and delays tumor burden [19,76]. Senescent abatement has
been shown to delay atherosclerosis, pulmonary fibrosis, neurodegenerative disease, heart failure and tumor onset [15,77–81]. We demonstrate that the UCP2 inhibitor, genipin, negated increases in mitochondrial OCR in Alkbh8def MEFs, as well as their glycolytic behavior.
Our study is an early example of how an epitranscriptomic defect can be
metabolically exploited to limit cell growth and may have potential
applications in killing tumors with similar genetic profiles.
We have previously reported that the SASP is redox-regulated
through a mechanism that involves redox-dependent transcriptional
activation and impeding inhibitory signaling phosphatases [14]. Selenium deprivation has been established to engage senescent programming and our findings further support the importance of selenoproteins
in this process likely through a similar redox based signaling process.
Our study further indicates that additional, adaptive responses are engaged in response to selenoprotein deficiency. Senescence engagement
coupled with stress resistance would create a microenvironment that is
ripe for disease development and that targeting the epitranscriptome in
combination with selenium supplementation may prove useful as a
therapeutic strategy for disease intervention (See Fig. 8).
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